Treatment of Hypertrophic Scars With Intradermal Botox
Status:
Unknown status
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
This is a prospective, open label, single center, self-controlled clinical study to
demonstrate the safety and efficacy of intradermal botulinum toxin in treating hypertrophic
scarring.
Phase:
Phase 2
Details
Lead Sponsor:
Roy G. Geronemus, M.D.
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A onabotulinumtoxinA